Related Experiment Video
Updated: May 21, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Adult refractory Still disease with atypical articular manifestations: efficacity of interleukin-6 antagonists
A Rkiouak1, K Ennibi, A Zinebi
1Service de médecine interne A, hôpital militaire d'instruction Mohammed V, Rabat, Morocco. arkiouak@yahoo.fr
Introduction:
Tocilizumab is a humanized monoclonal antibody directed against interleukin-6 receptor and is beginning to be reported as effective in some cases of Still's disease refractory in adults (ASD). ASD is rare, heterogeneous, with unpredictable evolution. The distal destructive arthritis represents a possible complication.
Patient:
We report an unusual case of adult-onset Still's disease with severe distal interphalangeal destructive arthritis with refractory early and prolonged remission after the first tocilizumab infusion.
Conclusion:
Tocilizumab can be used in patients with refractory ASD after failure or intolerance of conventional treatments.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies